Article info
Cancer genetics
Short report
Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB
- Correspondence to Dr Jianfeng Xu, Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL 60201, USA; jxu{at}northshore.org
Citation
Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB
Publication history
- Received June 22, 2020
- Revised November 18, 2020
- Accepted November 21, 2020
- First published December 21, 2020.
Online issue publication
February 18, 2022
Article Versions
- Previous version (21 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.